Oncology drug development and approval of systemic anticancer therapy by the U.S. Food and Drug Administration
about
Challenges in translating endpoints from trials to observational cohort studies in oncologyNOD-scidIl2rg (tm1Wjl) and NOD-Rag1 (null) Il2rg (tm1Wjl) : a model for stromal cell-tumor cell interaction for human colon cancerModeling timelines for translational science in cancer; the impact of technological maturationAcceptance of surrogate end points in clinical trials supporting approval of drugs for cancer treatment by the Japanese regulatory agency.Discrepancies in drug approvals: A global dilemma.Relationship between response rates and median progression-free survival in non-Hodgkin's lymphoma: A meta-analysis of published clinical trials.The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at approval of novel drugs
P2860
Q26746190-0D55AC75-C7C2-4B2A-8B74-4F94A86CF8CDQ33655771-E7B65640-88A1-4FF5-99F0-F01968F2A424Q36323995-629AFCA7-1FAA-4687-933E-B655D3CA1893Q47591645-57C758D0-B039-42B9-AF36-00F32E80D4CAQ47684206-95BCF60F-AE65-4328-96C3-20F80A6EAE9EQ50529551-90867BC1-9855-412B-B7B9-F628B9B940A7Q58718992-2A1A67AE-789D-4C45-8020-E10A4DF7EC2C
P2860
Oncology drug development and approval of systemic anticancer therapy by the U.S. Food and Drug Administration
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Oncology drug development and ...... . Food and Drug Administration
@ast
Oncology drug development and ...... . Food and Drug Administration
@en
type
label
Oncology drug development and ...... . Food and Drug Administration
@ast
Oncology drug development and ...... . Food and Drug Administration
@en
prefLabel
Oncology drug development and ...... . Food and Drug Administration
@ast
Oncology drug development and ...... . Food and Drug Administration
@en
P2093
P2860
P1433
P1476
Oncology drug development and ...... . Food and Drug Administration
@en
P2093
David Sermer
Kenneth Getz
Kenneth I Kaitin
Robert E Martell
P2860
P304
P356
10.1634/THEONCOLOGIST.2012-0235
P577
2012-12-20T00:00:00Z